# Single Rising Dose Study of BI 201335 ZW in Healthy Male Subjects

> **NCT02182271** · PHASE1 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 201335 ZW - single rising dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02182271
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-10
- **Primary completion:** 2004-10
- **Final completion:** —
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2014-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02182271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02182271, "Single Rising Dose Study of BI 201335 ZW in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02182271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*